Russell Investments Group, Ltd. Macrogenics Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Macrogenics Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 16,114 shares of MGNX stock, worth $51,725. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,114

Previous 18,390 12.38%

Holding current value

$51,725

Previous $78,000 32.05%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.0 - $5.55 $6,828 - $12,631	-2,276 Reduced 12.38%	16,114 $53,000
Q2 2024 Aug 08, 2024	BUY	$3.31 - $18.51 $8,049 - $45,016	2,432 Added 15.24%	18,390 $78,000
Q1 2024 May 08, 2024	BUY	$9.77 - $21.47 $6,018 - $13,225	616 Added 4.02%	15,958 $234,000
Q4 2023 Feb 05, 2024	SELL	$4.48 - $10.11 $61,129 - $137,950	-13,645 Reduced 47.07%	15,342 $147,000
Q3 2023 Nov 13, 2023	SELL	$4.48 - $6.19 $24,568 - $33,945	-5,484 Reduced 15.91%	28,987 $135,000
Q2 2023 Aug 10, 2023	BUY	$4.62 - $7.54 $66,098 - $107,874	14,307 Added 70.95%	34,471 $184,000
Q1 2023 May 09, 2023	SELL	$4.82 - $7.24 $87,319 - $131,159	-18,116 Reduced 47.32%	20,164 $144,000
Q4 2022 Feb 08, 2023	SELL	$3.34 - $6.98 $125,584 - $262,448	-37,600 Reduced 49.55%	38,280 $256,000
Q3 2022 Nov 04, 2022	BUY	$3.01 - $5.22 $139,363 - $241,686	46,300 Added 156.52%	75,880 $261,000
Q2 2022 Jul 29, 2022	BUY	$2.25 - $9.99 $33,525 - $148,851	14,900 Added 101.5%	29,580 $86,000
Q3 2021 Nov 08, 2021	SELL	$19.74 - $28.7 $905,434 - $1.32 Million	-45,868 Reduced 75.75%	14,680 $307,000
Q2 2021 Aug 04, 2021	SELL	$20.49 - $35.63 $754,995 - $1.31 Million	-36,847 Reduced 37.83%	60,548 $1.63 Million
Q1 2021 May 10, 2021	BUY	$18.99 - $33.2 $552,020 - $965,090	29,069 Added 42.54%	97,395 $3.1 Million
Q4 2020 Feb 08, 2021	SELL	$19.41 - $26.0 $379,310 - $508,092	-19,542 Reduced 22.24%	68,326 $1.56 Million
Q3 2020 Nov 09, 2020	BUY	$24.69 - $31.6 $621,002 - $794,803	25,152 Added 40.1%	87,868 $2.21 Million
Q2 2020 Aug 05, 2020	BUY	$5.2 - $29.12 $42,879 - $240,123	8,246 Added 15.14%	62,716 $1.75 Million
Q1 2020 May 06, 2020	BUY	$4.28 - $12.11 $233,131 - $659,631	54,470 New	54,470 $316,000
Q3 2019 Nov 01, 2019	SELL	$12.44 - $17.48 $563,357 - $791,599	-45,286 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$11.11 - $25.6 $503,127 - $1.16 Million	45,286 New	45,286 $813,000
Q3 2018 Oct 26, 2018	SELL	$19.26 - $23.46 $427,572 - $520,812	-22,200 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$19.78 - $24.67 $110,768 - $138,152	5,600 Added 33.73%	22,200 $458,000
Q1 2018 May 11, 2018	BUY	$18.89 - $32.46 $122,785 - $210,990	6,500 Added 64.36%	16,600 $418,000
Q4 2017 Feb 06, 2018	BUY	$16.19 - $20.3 $116,568 - $146,160	7,200 Added 248.28%	10,100 $196,000
Q3 2017 Nov 07, 2017	BUY	$15.52 - $18.94 $45,008 - $54,926	2,900	2,900 $54,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $197M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Macrogenics Inc Transaction History